Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease

Journal of Immunology Research
Shi-chun LuNing Li

Abstract

The aim of this study was to establish a hepatitis B virus (HBV) vaccination protocol among orthotopic liver transplantation (OLT) recipients under the coverage of a low-dose hepatitis B immunoglobulin (HBIG) combined with an antiviral agent prophylaxis protocol. Two hundred OLT recipients were included in this study. The vaccine was injected at months 0, 1, 2, and 6. Low-dose HBIG combined with antiviral agent prophylaxis protocol was continued before reestablishment of active immunity against HBV in order to maintain a steady anti-HBs titer. Active immunity against HBV was reestablished in 50 patients, for an overall response rate of 25%. Of the 50 patients, 24 discontinued HBIG without any HBV graft reinfection during a follow-up period of 26.13 ± 7.05 months. 21 patients discontinued both HBIG and antiviral agents during a follow-up period of 39.86 ± 15.47 months, and 4 patients among them appeared to be HBsAg positive. There was no recipient death or graft loss because of HBV reinfection. Vaccination preventing HBV reinfection for OLT recipients is feasible. The strategy withdrawal of HBIG with induction of active immunity against hepatitis B is reasonable for long-term survivors of OLT; however, discontinuation nucleoside...Continue Reading

References

Dec 16, 1993·The New England Journal of Medicine·D SamuelH Bismuth
Dec 16, 1993·The New England Journal of Medicine·R P Perrillo, A L Mason
Aug 8, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J S MarkowitzR W Busuttil
Dec 30, 1999·International Reviews of Immunology·Y M WenS H Zhou
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Sánchez-FueyoJ Rodés
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mario AngelicoGiuseppe Tisone
May 31, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ulrich BienzlePeter Neuhaus
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alberto Sanchez-FueyoAntoni Rimola
Sep 10, 2003·Transplantation Proceedings·E Albeniz ArbizuP Martin Davila
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ulrich BienzlePeter Neuhaus
Sep 27, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Peter StärkelYves Horsmans
Feb 7, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C-M LoJ Wong
Feb 24, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jens RosenauMichael P Manns
Jul 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L JiangW Wang

❮ Previous
Next ❯

Citations

Mar 4, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Afroditi OrfanidouEvangelos Cholongitas

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.